| Net Cash Provided by (Used in) Operating Activities |
$121,210 |
USD |
31% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$37,600 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
78,855,273 |
shares |
6.1% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$158,810 |
USD |
9.2% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$590,350 |
USD |
38% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$6,118,577 |
USD |
5.7% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,070,788 |
USD |
5.4% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$45,357,513 |
USD |
4.8% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |